Works matching IS 20590105 AND DT 2025 AND VI 10 AND IP 1
Results: 46
African swine fever virus vaccine strain Asfv-G-∆I177l reverts to virulence and negatively affects reproductive performance.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01099-9
- By:
- Publication type:
- Article
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01094-0
- By:
- Publication type:
- Article
Author Correction: Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01098-w
- By:
- Publication type:
- Article
Recent advances and perspectives on the development of circular RNA cancer vaccines.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01097-x
- By:
- Publication type:
- Article
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01076-2
- By:
- Publication type:
- Article
SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01095-z
- By:
- Publication type:
- Article
Functionality and translation fidelity characterization of mRNA vaccines using platform based mass spectrometry detection.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01082-4
- By:
- Publication type:
- Article
Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01073-5
- By:
- Publication type:
- Article
Structure-guided design of a prefusion GPC trimer induces neutralizing responses against LASV.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01090-4
- By:
- Publication type:
- Article
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01088-y
- By:
- Publication type:
- Article
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01089-x
- By:
- Publication type:
- Article
Product and trial design considerations on the path towards a vaccine to combat opioid overdose.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01083-3
- By:
- Publication type:
- Article
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01075-3
- By:
- Publication type:
- Article
Addressing unexpected bacterial RNA safety concerns of E. coli produced influenza NP through CpG loaded mutant.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01087-z
- By:
- Publication type:
- Article
LmCen<sup>−/−</sup> based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01070-8
- By:
- Publication type:
- Article
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01085-1
- By:
- Publication type:
- Article
Identifying vaccine-hesitant subgroups in the Western Pacific using latent class analysis.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01067-3
- By:
- Publication type:
- Article
Calboxyvinyl polymer adjuvant enhances respiratory iga responses through mucosal and systemic administration.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01086-0
- By:
- Publication type:
- Article
Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01084-2
- By:
- Publication type:
- Article
Author Correction: SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01078-0
- By:
- Publication type:
- Article
Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01079-z
- By:
- Publication type:
- Article
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01074-4
- By:
- Publication type:
- Article
Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01071-7
- By:
- Publication type:
- Article
A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01034-4
- By:
- Publication type:
- Article
Novel fusion protein REA induces robust prime protection against tuberculosis in mice.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01077-1
- By:
- Publication type:
- Article
Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01051-3
- By:
- Publication type:
- Article
Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01035-3
- By:
- Publication type:
- Article
Haemaphysalis longicornis subolesin controls the infection and transmission of severe fever with thrombocytopenia syndrome virus.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01061-1
- By:
- Publication type:
- Article
Recombinant production platform for Group A Streptococcus glycoconjugate vaccines.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01068-2
- By:
- Publication type:
- Article
Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01056-y
- By:
- Publication type:
- Article
Validation of a multiplexed immunoassay for immunological analysis of pre erythrocytic malaria vaccines.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01039-z
- By:
- Publication type:
- Article
TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01055-z
- By:
- Publication type:
- Article
HLA I immunopeptidome of synthetic long peptide pulsed human dendritic cells for therapeutic vaccine design.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01069-1
- By:
- Publication type:
- Article
Antibody responses against influenza A decline with successive years of annual influenza vaccination.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01057-x
- By:
- Publication type:
- Article
Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01054-0
- By:
- Publication type:
- Article
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01062-8
- By:
- Publication type:
- Article
Influenza A virus in dairy cattle: infection biology and potential mammary gland-targeted vaccines.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01063-7
- By:
- Publication type:
- Article
A broad spectrum Shigella vaccine based on VirG<sub>53</sub><sub>–</sub><sub>353</sub> multiepitope region produced in a cell-free system.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01064-6
- By:
- Publication type:
- Article
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01053-1
- By:
- Publication type:
- Article
A synthetic cyclic peptide for promoting antigen presentation and immune activation.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01050-4
- By:
- Publication type:
- Article
A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01060-2
- By:
- Publication type:
- Article
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01066-4
- By:
- Publication type:
- Article
Incremental benefit of high dose compared to standard dose influenza vaccine in reducing hospitalizations.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01065-5
- By:
- Publication type:
- Article
Development of broadly protective influenza B vaccines.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-024-01058-w
- By:
- Publication type:
- Article